| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-12 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |